fosaprepitant
Commercial- Indications
- Chemotherapy-induced nausea and vomiting
Company intelligence / Profile preview
SPES Pharmaceuticals Inc.
Plainsboro / North Brunswick Township (*multiple addresses used*), New Jersey, United Statesspespharma.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Commercial
01
Overview
The company’s lead product FOCINVEZ™ (fosaprepitant dimeglumine), a ready-to-use injectable antiemetic for chemotherapy-induced nausea and vomiting, was FDA-approved in August 2023. Other pipeline products are at various stages from preclinical to clinical development across oncology, CNS, and pain management. The company leverages proprietary formulation platforms to improve safety profiles and handling efficiency of existing molecules.[1][8][10]
- Therapeutic areas
- OncologyNeurology
- Modalities
- Proprietary new formulations (including ready-to-use injectables)Extended-release injectable drug delivery technologies[1][9]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Steriscience – manufacturing partner for FOCINVEZ™[8]Amneal Pharmaceuticals – commercialization partner for FOCINVEZ™ in the US market[8]YKY China – commercial distribution partnership in China[10]
Beyond the preview
Go deeper on SPES Pharmaceuticals Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SPES Pharmaceuticals Inc..